oncology

OCPC: In Session

Patient Perspectives About Cancer Clinical Pathways and Care Coordination

04/11/2023

Deborah E. Collyar

Deborah E. Collyar discusses how patients feel through their cancer experience and suggests ways to incorporate important components like social determinants of health; diversity, equity, and inclusion strategies; and cost considerations so...

Deborah E. Collyar discusses how...

04/11/2023

Journal of Clinical Pathways

Research Reports

Measuring Telehealth Quality in Cancer Care: We Don’t Know What We Don’t Know

11/15/2022

David Blaisdell

Tom Valuck, MD, JD

The authors evaluate key quality considerations related to the use of telehealth in oncology in the context of the National Committee for Quality Assurance and the National Quality Forum's recommendations and discuss strategies to enhance...

The authors evaluate key quality...

11/15/2022

Journal of Clinical Pathways

Case Report

Case Report and Literature Review of Giant Cutaneous Malignant Melanoma: What’s Keeping Patients Away?

09/23/2022

Jamie A Mawhinney, BA, BMBCh, MRCS (Eng)¹; Adrien Yvon, MBChB, MRes (Dist), MRCS (Eng)¹; Shahid Masood, MBBS, FFCPS (Plast), FRCS (Plast)¹

Jamie A Mawhinney, BA, BMBCh, MRCS (E...

This case report presents one of the largest cases of giant cutaneous malignant melanoma to date and the first in the literature to show excellent response to adjuvant immunotherapy.

This case report presents one of...

09/23/2022

ePlasty

Research Reports

08/15/2022

Stephen Hamilton, MD

Kathryn Christensen, MS

Margaret Rausa, PharmD

Nick Andrews, PharmD

Timothy Dollear, MS

Christopher Linkimer, CPA

Eric Gratias, MD, FAAP

Dr Hamilton and colleagues outline how eviCore Healthcare offered the option for payer clients to implement a biosimilar preferencing policy, analyzing how this policy affected the rate of biosimilar use and costs.

Dr Hamilton and colleagues...

08/15/2022

Journal of Clinical Pathways

From the Field

Referral Patterns and Treatment Preferences in Patients With Advanced Prostate Cancer: Differences Between Medical Oncologists and Urologists

10/20/2021

Ajeet Gajra, MD, FACP

Skyler Hime Rupard, MS

Yolaine Jeune-Smith, PhD

Bruce Feinberg, DO

Ajeet Gajra, MD, FACP, et al assessed the differences between medical oncologists and urologists regarding perceptions on timing of referral and treatment sequence decisions for patients with advanced prostate cancer

Ajeet Gajra, MD, FACP, et al...

10/20/2021

Journal of Clinical Pathways

Clinical Cases

Use of Medical-grade Honey on Oral Mucositis in Pediatric Oncology Patients

12/13/2017

Ferne T. Elsass, MSN, RN, CPN, CWON, presents her poster, “A Sweet Solution: The Use of Medical-grade Honey on Oral Mucositis in the Pediatric Oncology Patient,” which was exhibited at SAWC Fall 2017 in Las Vegas, NV.

Ferne T. Elsass, MSN, RN, CPN,...

12/13/2017

Wounds

Rapid Communication

A Sweet Solution: The Use of Medical-grade Honey on Oral Mucositis in the Pediatric Oncology Patient

12/11/2017

Ferne T. Elsass

12/11/2017

Wounds

Feature

The Evolution of Clinical Pathways for Oncology

10/27/2015

Winston Wong, PharmD, Editor-in-Chief

Abstract: A substantial portion of total medication costs is represented by the cost of specialty drugs, which only continues to rise. Oncology, in particular, is one of the three most costly specialty therapeutic...

...

10/27/2015

Journal of Clinical Pathways